 Mona Abaza
Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Otolaryngology | 10 | 2021 | 69 | 3.130 |
Why?
| | Voice Disorders | 8 | 2017 | 20 | 1.670 |
Why?
| | Internship and Residency | 8 | 2019 | 920 | 1.420 |
Why?
| | Personnel Selection | 4 | 2019 | 62 | 1.390 |
Why?
| | Laryngoscopy | 3 | 2023 | 90 | 0.820 |
Why?
| | Larynx | 3 | 2015 | 47 | 0.730 |
Why?
| | Physicians, Women | 1 | 2021 | 55 | 0.710 |
Why?
| | Learning | 1 | 2023 | 346 | 0.660 |
Why?
| | Leadership | 2 | 2021 | 291 | 0.630 |
Why?
| | Treatment Adherence and Compliance | 1 | 2017 | 18 | 0.570 |
Why?
| | Career Choice | 1 | 2018 | 178 | 0.540 |
Why?
| | Resilience, Psychological | 1 | 2018 | 95 | 0.530 |
Why?
| | Deglutition Disorders | 1 | 2017 | 117 | 0.510 |
Why?
| | Education, Medical | 1 | 2018 | 214 | 0.480 |
Why?
| | Injections | 1 | 2015 | 160 | 0.480 |
Why?
| | Simulation Training | 1 | 2015 | 62 | 0.460 |
Why?
| | Education, Medical, Undergraduate | 1 | 2016 | 160 | 0.440 |
Why?
| | Voice | 2 | 2017 | 8 | 0.440 |
Why?
| | Patient Care Team | 1 | 2017 | 517 | 0.410 |
Why?
| | Burnout, Professional | 1 | 2018 | 323 | 0.410 |
Why?
| | Occupational Diseases | 2 | 2006 | 129 | 0.400 |
Why?
| | Vocal Cords | 4 | 2006 | 25 | 0.390 |
Why?
| | Carcinoma, Hepatocellular | 2 | 2020 | 210 | 0.390 |
Why?
| | Hepatitis C | 2 | 2020 | 218 | 0.360 |
Why?
| | Education, Medical, Graduate | 3 | 2019 | 366 | 0.330 |
Why?
| | Liver Neoplasms | 2 | 2020 | 504 | 0.330 |
Why?
| | Inhibin-beta Subunits | 1 | 2006 | 5 | 0.260 |
Why?
| | Activins | 1 | 2006 | 26 | 0.260 |
Why?
| | Schistosomiasis | 1 | 2006 | 37 | 0.250 |
Why?
| | Job Application | 2 | 2015 | 10 | 0.230 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2006 | 286 | 0.220 |
Why?
| | Humans | 25 | 2023 | 114080 | 0.200 |
Why?
| | Postpoliomyelitis Syndrome | 1 | 2001 | 4 | 0.190 |
Why?
| | Glypicans | 1 | 2020 | 9 | 0.180 |
Why?
| | Dipeptidyl Peptidase 4 | 1 | 2020 | 11 | 0.180 |
Why?
| | Neurofibromatosis 2 | 2 | 1998 | 4 | 0.170 |
Why?
| | Equipment Design | 2 | 2015 | 503 | 0.170 |
Why?
| | Pilot Projects | 2 | 2019 | 1361 | 0.160 |
Why?
| | Voice Quality | 2 | 2014 | 15 | 0.160 |
Why?
| | Disability Evaluation | 1 | 2000 | 271 | 0.160 |
Why?
| | United States | 4 | 2019 | 12144 | 0.150 |
Why?
| | Otolaryngologists | 1 | 2017 | 10 | 0.140 |
Why?
| | Speech-Language Pathology | 1 | 2017 | 16 | 0.140 |
Why?
| | Educational Status | 1 | 2019 | 408 | 0.140 |
Why?
| | Organizational Culture | 1 | 2018 | 120 | 0.140 |
Why?
| | Interviews as Topic | 1 | 2019 | 576 | 0.130 |
Why?
| | Faculty, Medical | 1 | 2018 | 226 | 0.120 |
Why?
| | Female | 12 | 2021 | 59349 | 0.120 |
Why?
| | Clinical Clerkship | 1 | 2016 | 72 | 0.120 |
Why?
| | Competitive Behavior | 1 | 2015 | 38 | 0.120 |
Why?
| | Psychoses, Substance-Induced | 2 | 2007 | 12 | 0.120 |
Why?
| | Dysphonia | 1 | 2014 | 10 | 0.120 |
Why?
| | Speech Acoustics | 1 | 2014 | 9 | 0.120 |
Why?
| | Clinical Competence | 2 | 2019 | 882 | 0.120 |
Why?
| | Cell Division | 1 | 1996 | 754 | 0.120 |
Why?
| | Program Evaluation | 1 | 2018 | 820 | 0.110 |
Why?
| | Educational Measurement | 1 | 2016 | 235 | 0.110 |
Why?
| | Egypt | 2 | 2020 | 10 | 0.110 |
Why?
| | School Admission Criteria | 1 | 2013 | 20 | 0.110 |
Why?
| | Attitude | 1 | 2015 | 228 | 0.110 |
Why?
| | Electromyography | 2 | 2007 | 326 | 0.100 |
Why?
| | Correspondence as Topic | 1 | 2012 | 14 | 0.100 |
Why?
| | Male | 12 | 2018 | 55420 | 0.100 |
Why?
| | Societies, Medical | 1 | 2016 | 655 | 0.100 |
Why?
| | Students, Medical | 1 | 2016 | 262 | 0.100 |
Why?
| | Writing | 1 | 2012 | 82 | 0.090 |
Why?
| | Surgeons | 1 | 2015 | 236 | 0.090 |
Why?
| | Nasal Decongestants | 2 | 2007 | 8 | 0.080 |
Why?
| | Histamine H1 Antagonists | 2 | 2007 | 28 | 0.080 |
Why?
| | Anti-Ulcer Agents | 2 | 2007 | 15 | 0.080 |
Why?
| | Biomedical Research | 1 | 2015 | 582 | 0.080 |
Why?
| | Vocal Cord Paralysis | 2 | 2005 | 21 | 0.070 |
Why?
| | Analgesics | 1 | 2007 | 156 | 0.060 |
Why?
| | Music | 1 | 2006 | 39 | 0.060 |
Why?
| | Movement Disorders | 1 | 2005 | 48 | 0.060 |
Why?
| | Severity of Illness Index | 3 | 2014 | 2540 | 0.050 |
Why?
| | Glucocorticoids | 1 | 2007 | 526 | 0.050 |
Why?
| | Vagus Nerve Diseases | 1 | 2002 | 1 | 0.050 |
Why?
| | Cough | 1 | 2002 | 107 | 0.050 |
Why?
| | Laryngeal Diseases | 1 | 2001 | 21 | 0.050 |
Why?
| | Parkinson Disease | 1 | 2005 | 346 | 0.050 |
Why?
| | Amyloidosis | 1 | 2001 | 36 | 0.050 |
Why?
| | Middle Aged | 6 | 2006 | 26621 | 0.050 |
Why?
| | Cicatrix | 1 | 2001 | 49 | 0.050 |
Why?
| | alpha-Fetoproteins | 1 | 2020 | 31 | 0.040 |
Why?
| | Gastroesophageal Reflux | 1 | 2002 | 229 | 0.040 |
Why?
| | Adult | 5 | 2006 | 30395 | 0.040 |
Why?
| | Audiometry, Pure-Tone | 2 | 1998 | 22 | 0.040 |
Why?
| | Drug Prescriptions | 1 | 2001 | 237 | 0.040 |
Why?
| | Hepacivirus | 1 | 2020 | 228 | 0.040 |
Why?
| | Acute Disease | 1 | 2001 | 909 | 0.040 |
Why?
| | Ear Neoplasms | 1 | 1998 | 4 | 0.040 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2001 | 239 | 0.040 |
Why?
| | Neurilemmoma | 1 | 1998 | 19 | 0.040 |
Why?
| | Adipose Tissue | 1 | 2001 | 545 | 0.040 |
Why?
| | Stroke | 1 | 2005 | 1019 | 0.030 |
Why?
| | Reproducibility of Results | 2 | 2014 | 2764 | 0.030 |
Why?
| | Spinal Neoplasms | 1 | 1996 | 26 | 0.030 |
Why?
| | Follow-Up Studies | 3 | 2001 | 4392 | 0.030 |
Why?
| | Hearing Loss | 1 | 1998 | 183 | 0.030 |
Why?
| | Speech Production Measurement | 1 | 2014 | 12 | 0.030 |
Why?
| | Biomarkers, Tumor | 1 | 2020 | 1032 | 0.030 |
Why?
| | Judgment | 1 | 2014 | 55 | 0.030 |
Why?
| | Area Under Curve | 1 | 2014 | 273 | 0.030 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 131 | 0.030 |
Why?
| | Observer Variation | 1 | 2014 | 298 | 0.030 |
Why?
| | Speech Perception | 1 | 2014 | 73 | 0.030 |
Why?
| | ROC Curve | 1 | 2014 | 441 | 0.030 |
Why?
| | Prospective Studies | 2 | 2014 | 6198 | 0.030 |
Why?
| | Biomarkers | 1 | 2020 | 3397 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2014 | 1791 | 0.020 |
Why?
| | Aged | 3 | 2005 | 18973 | 0.020 |
Why?
| | Age Factors | 1 | 1996 | 2886 | 0.020 |
Why?
| | Patient Selection | 1 | 2012 | 629 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 2 | 1998 | 3039 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2014 | 3007 | 0.020 |
Why?
| | Algorithms | 1 | 2014 | 1469 | 0.020 |
Why?
| | Risk Assessment | 2 | 2005 | 2958 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2015 | 4404 | 0.010 |
Why?
| | Age Distribution | 1 | 2005 | 341 | 0.010 |
Why?
| | Brain | 1 | 1996 | 2355 | 0.010 |
Why?
| | Sex Distribution | 1 | 2005 | 336 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2015 | 4598 | 0.010 |
Why?
| | Hoarseness | 1 | 2001 | 4 | 0.010 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 2001 | 33 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 2001 | 117 | 0.010 |
Why?
| | Biopsy, Needle | 1 | 2001 | 180 | 0.010 |
Why?
| | Medical History Taking | 1 | 2001 | 115 | 0.010 |
Why?
| | Transplantation, Autologous | 1 | 2001 | 175 | 0.010 |
Why?
| | Drug Therapy | 1 | 2001 | 74 | 0.010 |
Why?
| | Steroids | 1 | 2001 | 143 | 0.010 |
Why?
| | Drug Utilization | 1 | 2001 | 164 | 0.010 |
Why?
| | Incidence | 1 | 2005 | 2314 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2002 | 1331 | 0.010 |
Why?
| | Speech Reception Threshold Test | 1 | 1998 | 1 | 0.010 |
Why?
| | Reflex, Vestibulo-Ocular | 1 | 1998 | 9 | 0.010 |
Why?
| | Adolescent | 1 | 1996 | 17811 | 0.010 |
Why?
| | Prognosis | 1 | 2005 | 3315 | 0.010 |
Why?
| | Anti-Inflammatory Agents | 1 | 2001 | 445 | 0.010 |
Why?
| | Evoked Potentials, Auditory, Brain Stem | 1 | 1998 | 47 | 0.010 |
Why?
| | Child | 1 | 1996 | 18408 | 0.010 |
Why?
| | Chronic Disease | 1 | 2002 | 1579 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2005 | 6307 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2001 | 12521 | 0.010 |
Why?
| | Practice Patterns, Physicians' | 1 | 2001 | 1175 | 0.010 |
Why?
| | Risk Factors | 1 | 2001 | 8612 | 0.000 |
Why?
| | Treatment Outcome | 1 | 2001 | 9051 | 0.000 |
Why?
|
|
Abaza's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|